Search - tctmd.com

Displaying 61 - 80 of 1031

Sort: Relevancy | Date

Presentation TCT 2023

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 25, 2023

Presentation TCT 2023

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 497: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 4 Clinical Year Outcomes

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

Presenter: SIMONE FEZZI

October 25, 2023

Presentation TCT 2023

TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days

Presenter: Sho Torii

October 25, 2023

Presentation TCT 2023

TCT 576: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final 5 Year Clinical Outcomes

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Presenter: Eric Secemsky

October 25, 2023

Presentation TCT 2023

TCT 566: Tyrosine Polycarbonate Bioresorbable Scaffold for Below-the Knee Application: Pilot Study of Biocompatibility in Small Caliber Porcine Peripheral Arteries

Presenter: Mateusz Kachel

October 25, 2023

Presentation TCT 2023

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

Presenter: Tony Das

October 24, 2023

Presentation TCT 2023

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

Presenter: Juan Granada

October 24, 2023

Presentation TCT 2023

Bioresorbable Stent Technology for BTK Disease: Putting the Trials Into Perspective

Presenter: Brian DeRubertis

October 24, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

Presentation TCT 2022

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 52: Structural and Functional Evaluation of Coronary Arteries Treated With Absorb Bioresorbable Vascular Scaffold at 5-Year Follow-Up

Presenter: Luis Goncalves-Ramírez

September 17, 2022

Presentation TCT 2022

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

Presenter: Giulia Masiero

September 17, 2022

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

Advertisement

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

TCT 497: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 4 Clinical Year Outcomes

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days

TCT 576: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final 5 Year Clinical Outcomes

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

TCT 566: Tyrosine Polycarbonate Bioresorbable Scaffold for Below-the Knee Application: Pilot Study of Biocompatibility in Small Caliber Porcine Peripheral Arteries

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

Bioresorbable Stent Technology for BTK Disease: Putting the Trials Into Perspective

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

TCT 52: Structural and Functional Evaluation of Coronary Arteries Treated With Absorb Bioresorbable Vascular Scaffold at 5-Year Follow-Up

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content